Martin J. Loscalzo, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 864 Neighbors Way, Perkasie, PA 18944 Phone: 215-285-7596 |
News Archive
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
A new study has illustrated the risks involved when statin treatment is discontinued after a stroke and shows an increased risk of death or dependency is present for up to 90 days.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
Both high and low frequency hearing impairment have been linked with sleep apnea in a new study of nearly 14,000 individuals.
A new minimally invasive procedure is hitting its mark with certain types of low back and leg pain sufferers, significantly reducing their pain and disability.
› Verified 3 days ago